English
Structure via PubChem · Public domain (PubChem)
tesaglitazar
Sign in to saveTesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
Chemical data
- Formula
- C20H24O7S
- Molecular weight
- 408.5 g/mol
- IUPAC name
- (2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 3
- Molecule type
- Small molecule
- Indications
- type 2 diabetes mellitus
via ChEMBL · EBI
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Tesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
The drug had completed several phase III clinical trials, however in May, 2006 AstraZeneca announced that it had discontinued further development.
Excerpted from Wikipedia’s “tesaglitazar” article, available under the CC BY-SA 4.0 licence.